URI:
   DIR Return Create A Forum - Home
       ---------------------------------------------------------
       Iranian Tissue Engineering
  HTML https://ite.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: Marketing and Tissue Engineering
       *****************************************************
       #Post#: 73--------------------------------------------------
       Nerve Repair and Regeneration Market worth $7.8 billion by 2018
   DIR By: nourani
       Date: February 1, 2015, 7:42 pm
       ---------------------------------------------------------
       This report studies the global nerve repair and regeneration
       market over the forecast period of 2013 to 2018.
       The global nerve repair and regeneration market is valued at
       $4.5 billion in 2013 and is poised to reach $7.5 billion by
       2018, at a CAGR of 11.5%.
       The nerve repair and regeneration market is categorized into two
       major segments, namely, peripheral nerve repair (direct nerve
       repair, nerve grafting, and stem cell therapy) and
       neuromodulation. Neuromodulation is considered as a potential
       upcoming market segment. The favorable reimbursement policies,
       technological advancements, and strong impact of this technology
       on treating disorders such as Parkinson’s, Alzheimer’s,
       epilepsy, and sleep apnea will be the major drivers for this
       market. The peripheral nerve repair segment is expected to grow
       at a lower but healthy CAGR in the next five years. The
       increasing incidence of peripheral nerve injuries and enhanced
       efficacy of biomaterials in treating nerve injuries are the
       major factors driving the market growth. However, factors such
       as the lack of trained professionals and lack of patient and
       surgeon awareness about biomaterials and Neuromodulation devices
       are expected to hamper the market growth.
       Novel therapies (such as stem cell therapy)and emerging markets
       provide a vast opportunity for market growth. Estimates suggest
       that around 700,000 peripheral nerve repair surgeries are
       performed every year across the world. However, the penetration
       rate of stem cell therapy is less than 1% in all these
       surgeries. Furthermore, emerging countries such as India, China,
       South Africa, and Australia offer huge growth opportunities with
       their diversified healthcare markets. The huge population base,
       especially in India and China, and aging population offers a
       sustainable market for nerve repair and regeneration surgeries.
       The major challenges for the market are donor site morbidity and
       inadequate nerve regeneration by conduits. The co-occurring
       diseases through nerve grafting surgeries and advancement of
       conduits for aiding the regeneration of long nerve gaps are the
       primary challenges that have to be overcome by the technology
       providers.
       The internal neuromodulation device market accounts for the
       largest share of around87% and is expected to grow at a
       double-digit CAGR in the next five years. The improved
       technology and effective outcomes across sub-segments such as
       spinal cord stimulation, deep brain stimulation, sacral nerve
       stimulation, and vagus nerve stimulation propel the growth of
       this market.
       The global biomaterials nerve repair and regeneration market is
       estimated to grow at a healthy CAGR of more than 11%. The
       favorable growth is due to a wide range of innovative products
       such as nerve conduits, nerve wraps, nerve connectors, and nerve
       protectors.
       North America accounts for the largest share of the global nerve
       repair and regeneration market, in 2013. However, the RoW region
       is expected to grow at a higher CAGR in the forecast period.
       This is due to factors such as rising awareness, growing demand
       for nerve repair products, and increased investments in regions
       such as the Middle East and LATAM.
       Major players in the neurostimulation market include Medtronic
       (U.S.), Boston Scientific (U.S.), St. Jude Medical (U.S.), and
       Cyberonics (U.S.), whereas the peripheral nerve repair market is
       dominated by Integra LifeSciences Corporation (U.S.), Stryker
       Corporation (U.S.), and AxoGen, Inc. (U.S.).
       About MarketsandMarkets
       MarketsandMarkets is a global market research and consulting
       company based in the U.S. We publish strategically analyzed
       market research reports and serve as a business intelligence
       partner to Fortune 500 companies across the world.
       MarketsandMarkets also provides multi-client reports, company
       profiles, databases, and custom research services. M&M covers
       thirteen industry verticals, including advanced materials,
       automotives and transportation, banking and financial services,
       biotechnology, chemicals, consumer goods, energy and power, food
       and beverages, industrial automation, medical devices,
       pharmaceuticals, semiconductor and electronics, and
       telecommunications and IT.
       We at MarketsandMarkets are inspired to help our clients grow by
       providing apt business insight with our huge market intelligence
       repository.
       Contact:
       Mr. Rohan
       North - Dominion Plaza,
       17304 Preston Road,
       Suite 800, Dallas, TX 75252
       Tel: +1-888-6006-441
       Email: sales@marketsandmarkets.com
       *****************************************************
       Page 1 of 1